Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Evolent Health, Inc (EVH : NYSE)

• Company Description    Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. Number of Employees: 4,500

• Price / Volume Information    Yesterday's Closing Price: $4.96 Daily Weekly Monthly 20 Day Moving Average: 2,699,809 shares Shares Outstanding: 117.51 (millions) Market Capitalization: $582.84 (millions) Beta: 0.58 52 Week High: $15.56 52 Week Low: $5.98 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -37.53% -39.17% 12 Week -46.67% -48.88% Year To Date -55.91% -61.46%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1812 N. MOORE STREET SUITE 1705 - ARLINGTON,VA 22209 USA ph: 571-389-6000 fax: 571-389-6001 sfrank@evolent.com http://www.evolent.com

• General Corporate Information    Officers Seth Blackley - Chief Executive Officer and Director John Johnson - Chief Financial Officer Aammaad Shams - Chief Accounting Officer Toyin Ajayi - Director Craig Barbarosh - Director Peer Information Evolent Health, Inc (HLIS) Evolent Health, Inc (AZTA) Evolent Health, Inc (APYI) Evolent Health, Inc (RNVA) Evolent Health, Inc (HMSY) Evolent Health, Inc (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 30050B101 SIC: 8741 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/19/26 Share - Related Items Shares Outstanding: 117.51 Most Recent Split Date: (:1) Beta: 0.58 Market Capitalization: $582.84 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.01 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.21 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/19/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.65 Price/Cash Flow: 3.27 Price / Sales: 0.28 EPS Growth vs. Year Ago Period: 0.00% vs. Previous Quarter: 52.94% Sales Growth vs. Year Ago Period: -22.83% vs. Previous Quarter: 7.92% ROE 09/30/25 - 1.74 06/30/25 - 1.83 03/31/25 - 3.64 ROA 09/30/25 - 0.64 06/30/25 - 0.70 03/31/25 - 1.44 Current Ratio 09/30/25 - - 06/30/25 - 1.01 03/31/25 - 0.98 Quick Ratio 09/30/25 - - 06/30/25 - 1.01 03/31/25 - 0.98 Operating Margin 09/30/25 - 0.80 06/30/25 - 0.81 03/31/25 - 1.53 Net Margin 09/30/25 - -6.24 06/30/25 - -5.94 03/31/25 - -4.54 Pre-Tax Margin 09/30/25 - - 06/30/25 - -5.99 03/31/25 - -4.56 Book Value 09/30/25 - - 06/30/25 - 7.63 03/31/25 - 7.97 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - - 06/30/25 - 0.72 03/31/25 - 0.69 Debt-to-Capital 09/30/25 - - 06/30/25 - 36.57 03/31/25 - 36.45

Powered by Zacks Investment Research ©